Portfolio company Delix Therapeutics in the news: Forbes Article “Delix Therapeutics Pursues A Psychedelic-Inspired Medicine Without The Trip”

The greatest return is serving those who put their lives on the line: our nation’s high-risk public servants.

Linkedin-in

Risk & Return 2021. All rights reserved.